Literature DB >> 10728905

ACNU, MTX and 5-FU penetration of rat brain tissue and tumors.

T Y Huang1, N Arita, T Hayakawa, Y Ushio.   

Abstract

The distribution of radio-labeled ACNU, MTX and 5-FU in brain and tumor tissue was studied in female Wistar rats by macroautoradiography after intrathecal administration. In normal rats, ACNU and 5-FU, administered intracisternally, distributed rapidly in the subarachnoid space, ventricular system and cerebrospinal fluid (CSF). 5-FU and MTX penetrated the brain deeply; the diffusional transport of ACNU was limited to a depth of 1 or 2 mm from the CSF surface of the brain. MTX and 5-FU clearance into the blood circulation was rather slow while ACNU cleared relatively quickly. The half time of ACNU, 5-FU and MTX radioactivity at the ventricular surface was 10, 21, and 110 min, respectively, at their maximal concentration after intracisternal administration. In rats with leptomeningeal tumor induced by intracisternal inoculation of Walker 256 cells, the distribution patterns of ACNU, 5-FU, and MTX were essentially the same as in normal rats despite 10-20 cell layers of tumor growing in the subarachnoid space. 5-FU and MTX were able to penetrate tumor masses in the subarachnoid space; MTX penetration was slower than that of 5-FU and ACNU failed to penetrate to more than a depth of 1 or 2 mm from the tumor surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10728905     DOI: 10.1023/a:1006377312403

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

Review 1.  The cellular pharmacology of methotrexate.

Authors:  I D Goldman; L H Matherly
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

2.  Current status of intrathecal chemotherapy for human meningeal neoplasms.

Authors:  W A Bleyer
Journal:  Natl Cancer Inst Monogr       Date:  1977-12

3.  The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier.

Authors:  V A Levin; H D Landahl; M A Freeman-Dove
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

4.  Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro.

Authors:  C J Cheng; S Fujimura; D Grunberger; I B Weinstein
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

Review 5.  Chemotherapy of malignant gliomas.

Authors:  Y Ushio; T Hayakawa; H Hasegawa; K Yamada; N Arita
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

6.  Meningeal carcinomatosis: development of an experimental model.

Authors:  Y Ushio; N L Chernik; J B Posner; W R Shapiro
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

7.  [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].

Authors:  M Nagatani; N Arita; Y Ushio; T Hayakawa; H Tzuu-Yuan; T Yoshimine; S Mori; H Mogami
Journal:  No To Shinkei       Date:  1986-11

Review 8.  Central nervous system pharmacology of antileukemic drugs.

Authors:  F M Balis; D G Poplack
Journal:  Am J Pediatr Hematol Oncol       Date:  1989

9.  Alteration of blood-CSF barrier by tumor invasion into the meninges.

Authors:  Y Ushio; K Shimizu; Y Aragaki; N Arita; T Hayakawa; H Mogami
Journal:  J Neurosurg       Date:  1981-09       Impact factor: 5.115

10.  Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas.

Authors:  K W Kohn
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

View more
  5 in total

Review 1.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 2.  Strategies for increasing drug delivery to the brain: focus on brain lymphoma.

Authors:  Tali Siegal; Ester Zylber-Katz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 5.577

3.  Stereotactic Radiosurgery as Part of Multimodal Treatment in a Bulky Leptomeningeal Recurrence of Breast Cancer.

Authors:  Matthew H Bertke; Eric C Burton; Joseph N Shaughnessy
Journal:  Cureus       Date:  2016-03-08

4.  Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases.

Authors:  Michael C Burger; Marlies Wagner; Kea Franz; Patrick N Harter; Oliver Bähr; Joachim P Steinbach; Christian Senft
Journal:  J Clin Med       Date:  2018-08-14       Impact factor: 4.241

5.  Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.

Authors:  Michael C Burger; Pia S Zeiner; Kolja Jahnke; Marlies Wagner; Michel Mittelbronn; Joachim P Steinbach
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.